Blogs

Latest Blogs

The Silence of the Genes: Unlocking Antisense Oligonucleotide Therapies for the Renin-Angiotensin-Aldosterone System

The field of gene therapy is rapidly evolving, with antisense oligonucleotide therapies emerging as powerful tools for modulating gene expression.…

A controlled detonation: Targeted antibody drug conjugates (ADCs) for oncology

Are antibody-drug conjugates (ADCs), principally comprised of an antibody, a cytotoxic payload and a linker, the next therapeutic modality of…

The mpox outbreak: Variants, transmission and the boost for vaccine manufacturers

Following Covid-19, the world is collectively on high alert for anything that could indicate another pandemic. What do we know…

The STING in the tail: How our own defense mechanisms to infection may be working against us

In this latest blog, we explore this pathway, its burgeoning links to multiple diseases and how biomarker profiling can assist…

Falling drug approval rates: What should we be doing differently?

Over the years, this failure rate of drug approvals has not seen significant improvement, which begs the question - why?…

Patient Derived Organoids: Shaping the Fight Against Paediatric Brain Cancer

We highlight some of the exciting translational tools that have been developed to understand brain cancer and how these are…

World Multiple Sclerosis Day 2024: Wider access to crucial antibody therapies

Quick Links

Talk to our Biomarker Experts